As a follow-up to MSAA’s onlin …
Read News ArticleCategory: Latest News
Zinbryta® Withdrawn from Marketplace
On March 2, 2018, Biogen and A …
Read News ArticleMSAA Draws Attention to Multiple Sclerosis Progression during MS Awareness Month
The organization will host a s …
Read News ArticleFDA Approves Three-Times Weekly Dose of Glatopa®
Sandoz, a Novartis division, a …
Read News ArticleBloomberg Senior Executive Editor Among Honorees at National Annual Benefit
John McCorry, Senior Executive …
Read News ArticleFDA Grants Gilenya® Breakthrough Therapy Designation for Pediatric MS
On December 18, 2017, Novartis …
Read News ArticleHighlights from the 2017 Joint ECTRIMS-ACTRIMS Meeting
MSParis2017 was this year’s jo …
Read News ArticleNew Publications to Manage Multiple Sclerosis from MSAA
Free Publications Providing Ex …
Read News ArticleMSAA Expands MRI Assistance and Helpline Hours
To help meet the escalating de …
Read News ArticleFDA Approves Two Doses of Generic Copaxone for MS
On October 4, 2017, Mylan anno …
Read News Article